Actively Recruiting
Additive Effects of Alternative Nostril Breathing with Pharmacological Management on Dyspnea and Control Pause in Patients with Bronchial Asthma
Led by Foundation University Islamabad · Updated on 2024-09-24
32
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Bronchial asthma is a common chronic condition characterized by inflammation and narrowing of the airways, causing repeated episodes of breathlessness, wheezing, and difficulty breathing. This research aims to compare the effects of alternative nostril breathing combined with standard pharmacological management against pharmacological management alone on symptoms such as dyspnea, control pause, asthma control, and peak expiratory flow rate in patients with bronchial asthma. Participants will be randomly assigned to one of two groups: one group will practice alternative nostril breathing alongside their prescribed asthma medications, while the other group will receive only the pharmacological treatment as prescribed by a pulmonologist. The breathing exercises consist of slow, deep inhalations and exhalations through alternate nostrils with breath holds, supervised twice weekly by a physiotherapist and practiced at home five days a week for a total of four weeks. The medication group follows a stepwise approach adjusted according to symptoms and severity over the same four-week period. During the study, participants will have their symptoms and lung function assessed before and after the four-week treatment period. Measurements include dyspnea levels, control pause time, asthma control status, and peak expiratory flow rate. A home diary will be used to ensure adherence to breathing exercises. The study monitors these outcomes to evaluate the combined effect of breathing exercises and medication on asthma management.
CONDITIONS
Brief Title
Additive Effects of Alternative Nostril Breathing with Pharmacological Management on Dyspnea and Control Pause in Patients with Bronchial Asthma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 45 years
- Both males and females
- Grade 1 to Grade 4 on Modified MRC dyspnea scale
- Asthma severity classified as intermediate, mild persistent, or moderate persistent according to national asthma education and prevention guidelines
You will not qualify if you...
- Patients with acute exacerbation of COPD or status asthmaticus
- Patients diagnosed with acute infections
- Patients unable to follow commands or instructions
- Asthma patients with control pause duration greater than 40 seconds
- Patients in the red zone of asthma action plan with peak expiratory flow rate less than 50%
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 4 weeks
Participants receive either alternative nostril breathing with pharmacological management or pharmacological management alone for bronchial asthma.
Two supervised sessions per week plus home practice for 5 days per week in the breathing exercise group; medication as prescribed by pulmonologist in the pharmacological therapy group.
Trial Site Locations
Total: 1 location
1
Foundation University College of Physical Therapy
Rawalpindi, Punjab Province, Pakistan, 46000
Actively Recruiting
Research Team
B
Bazkha Tariq Aslam Khawaja, DPT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here